Almac Group, a global contract development and manufacturing organization, has launched its new Almac Pod service in the U.S. for temperature controlled shipping.

The Almac Pod was designed to address cost, logistical and compliance challenges and was originally released in Europe. The Pod service incorporates Almac’s global courier network and phase change material technology (PCM) to create a temperature-controlled shipping for global clinical supply customers.

According to the company, the Almac Pod offers a “Protected, Optimized and Dynamic” solution for biologics or difficult to handle products that safeguards products and mitigates against temperature excursions of clinical shipments.

Leon Supplee, director of logistics, Almac Clinical Services, said, “On the cusp of our success launching the Almac Pod in Europe, we have expanded our new temperature-controlled shipping service solution to the U.S. and internationally. Our customers continuously need a solution to keep pace with rapidly growing demand for controlled temperature shipments. With increased volume, the Almac Pod allows us to build on our streamlined clinical trial supply chain. The service has equipped us, and our clients, to work seamlessly across the logistics process by protecting temperature controlled products and compares more effectively than traditional water-based solutions. The Almac Pod is fully GDP-compliant and is available as part of Almac’s end-to-end, global supply chain management solution – your product, safe in our hands.”